Pentifylline

This classification denotes a phosphodiesterase inhibitor and antiplatelet agent with the molecular formula C13H20N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MBM1C4K26S, chemically known as 3,7-dimethyl-1-hexyl-1h,3h-purin-2,6-dione but generally known as pentifylline, which bears US NIH Compound Identifier 70569. European Medicines Agency schedules Pentifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09694MIG. The term PENTIFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules pentifylline in its Anatomical Therapeutic Chemical (ATC) Classification. PENTIFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentifylline under HS 29399900 and SITC 54149. As of Q4 2014, PENTIFYLLINE remains the US FDA Preferred Term for this commodity. Pentifylline bears US NLM identifiers UMLS ID C0070313 and NCI Concept Code C66344. SMILES: O=c1n(CCCCCC)c(=O)n(c2ncn(c12)C)C.